{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:15:47Z","timestamp":1790748947287,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["F4701-B20"],"award-info":[{"award-number":["F4701-B20"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["F4704-B20"],"award-info":[{"award-number":["F4704-B20"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jaip.2019.01.006","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T01:32:37Z","timestamp":1549330357000},"page":"1125-1133.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":193,"title":["Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome"],"prefix":"10.1016","volume":"7","author":[{"given":"Peter","family":"Valent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Bonadonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Brockow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Niedoszytko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boguslaw","family":"Nedoszytko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Siebenhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang R.","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna N.G.","family":"Oude Elberink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Alvarez-Twose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Sotlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke C.","family":"Kluin-Nelemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Gotlib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurd","family":"Broesby-Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Horny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Triggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Arock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence B.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean D.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2019.01.006_bib1","first-page":"3","article-title":"Mast cells and basophils","volume":"16","author":"Schwartz","year":"2002","journal-title":"Clin Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2019.01.006_bib3","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/eji.201040559","article-title":"Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity","volume":"40","author":"Galli","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib4","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1365-2222.2011.03781.x","article-title":"The role of basophils in the pathogenesis of allergic disease","volume":"41","author":"Falcone","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.01.006_bib5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2019.01.006_bib6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1146\/annurev.immunol.17.1.931","article-title":"The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology","volume":"17","author":"Kinet","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0065-2776(01)76022-1","article-title":"Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function","volume":"76","author":"Nadler","year":"2000","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10238-005-0064-5","article-title":"Human basophils as effectors and immunomodulators of allergic inflammation and innate immunity","volume":"5","author":"Gibbs","year":"2005","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jaip.2019.01.006_bib9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/0091-6749(94)90345-X","article-title":"The clinical relevance of basophil releasability","volume":"94","author":"Marone","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib10","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.4049\/jimmunol.165.10.5913","article-title":"Multiple defects in Fc epsilon RI signaling in Syk-deficient nonreleaser basophils and IL-3-induced recovery of Syk expression and secretion","volume":"165","author":"Kepley","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib11","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0161-5890(02)00082-2","article-title":"Association of the Src homology 2 domain-containing inositol 5' phosphatase (SHIP) to releasability in human basophils","volume":"38","author":"MacDonald","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib12","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1398-9995.2012.02879.x.","article-title":"The interaction between Lyn and Fc\u03b5RI\u03b2 is indispensable for Fc\u03b5RI-mediated human mast cell activation","volume":"67","author":"Okayama","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.01.006_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2222.2010.03667.x","article-title":"Characterization of syk expression in human lung mast cells: relationship with function","volume":"41","author":"Havard","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.01.006_bib14","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1073\/pnas.86.14.5542","article-title":"Interleukin 3 activates human blood basophils via high-affinity binding sites","volume":"86","author":"Valent","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2019.01.006_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1084\/jem.175.1.237","article-title":"c-kit ligand: a unique potentiator of mediator release by human lung mast cells","volume":"175","author":"Bischoff","year":"1992","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2019.01.006_bib16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000236568","article-title":"Specific activation of human mast cells by the ligand for c-kit: comparison between lung, uterus and heart mast cells","volume":"102","author":"Sperr","year":"1993","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib17","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1398-9995.2012.02859.x","article-title":"Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in na\u00efve mice","volume":"67","author":"Komai-Koma","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.01.006_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/ACI.0b013e3283036a90","article-title":"Understanding the mechanisms of anaphylaxis","volume":"8","author":"Peavy","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaci.2009.08.035","article-title":"Mechanisms of mast cell signaling in anaphylaxis","volume":"124","author":"Metcalfe","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000315937","article-title":"Anaphylaxis: mechanisms of mast cell activation","volume":"95","author":"Kalesnikoff","year":"2010","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.jaip.2019.01.006_bib21","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","article-title":"Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with \u201cidiopathic\u201d anaphylaxis","volume":"110","author":"Akin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2019.01.006_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000096442","article-title":"Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: monoclonal mast cell activation syndrome","volume":"142","author":"Sonneck","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib23","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaci.2011.04.037","article-title":"Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations","volume":"128","author":"Hamilton","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000323763","article-title":"Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria","volume":"156","author":"Valent","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib26","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/all.12126","article-title":"Mast cell activation syndromes: definition and classification","volume":"68","author":"Valent","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.01.006_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJM198707023170106","article-title":"Mediators of immediate hypersensitivity reactions","volume":"317","author":"Serafin","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.01.006_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1398-9995.1988.tb05044.x","article-title":"The contribution of mast cell mediators to acute allergic reactions in human skin and airways","volume":"43","author":"Holgate","year":"1988","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.01.006_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1409760","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.01.006_bib32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000144042","article-title":"Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production","volume":"147","author":"Butterfield","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0167-5699(90)90176-A","article-title":"Mast cells as a source of multifunctional cytokines","volume":"11","author":"Gordon","year":"1990","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaip.2019.01.006_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa070030","article-title":"Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis","volume":"358","author":"Vadas","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.01.006_bib35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaci.2012.08.016","article-title":"Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis","volume":"131","author":"Vadas","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12634","article-title":"Mast cells as sources of cytokines, chemokines, and growth factors","volume":"282","author":"Mukai","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2019.01.006_bib37","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","article-title":"Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis","volume":"316","author":"Schwartz","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.01.006_bib38","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jaci.2005.12.1356","article-title":"Prolonged elevation of serum tryptase in idiopathic anaphylaxis","volume":"117","author":"Shanmugam","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.iac.2006.05.010","article-title":"Diagnostic value of tryptase in anaphylaxis and mastocytosis","volume":"26","author":"Schwartz","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2019.01.006_bib40","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1365-2222.2010.03582.x","article-title":"Serum total tryptase levels are increased in patients with active chronic urticaria","volume":"40","author":"Ferrer","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.01.006_bib41","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.138.7.2184","article-title":"Evaluation of human peripheral blood leukocytes for mast cell tryptase","volume":"138","author":"Castells","year":"1987","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib42","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2004.02.032","article-title":"Expression of alpha-tryptase and beta-tryptase by human basophils","volume":"113","author":"Jogie-Brahim","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib43","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1182\/blood.V98.8.2580","article-title":"Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms","volume":"98","author":"Samorapoompichit","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2019.01.006_bib44","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/all.13226","article-title":"Validation of international consensus equation for acute serum total tryptase in mast cell activation: a perioperative perspective","volume":"72","author":"Baretto","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.01.006_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1067\/mai.2000.107600","article-title":"Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study","volume":"106","author":"Lin","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib46","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1056\/NEJM198312293092603","article-title":"Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites","volume":"309","author":"Keyzer","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.01.006_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0750-7658(05)81026-3","article-title":"Improved diagnosis of anaphylactoid reactions by measurement of serum tryptase and urinary methylhistamine","volume":"12","author":"Watkins","year":"1993","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.jaip.2019.01.006_bib48","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0091-6749(94)90371-9","article-title":"Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation","volume":"93","author":"Awad","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib49","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1398-9995.2007.01616.x","article-title":"Salicylamide-induced anaphylaxis: increased urinary leukotriene E4 and prostaglandin D2 metabolite","volume":"63","author":"Ono","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.01.006_bib50","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaip.2014.06.011","article-title":"Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11\u03b2-prostaglandin2\u03b1","volume":"2","author":"Ravi","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.01.006_bib51","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0091-6749(91)90094-5","article-title":"Monitoring human basophil activation via CD63 monoclonal antibody 435","volume":"88","author":"Knol","year":"1991","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib52","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1067\/mai.2002.125257","article-title":"Recombinant allergens promote expression of CD203c on basophils in sensitized individuals","volume":"110","author":"Hauswirth","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib53","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000077351","article-title":"The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis","volume":"133","author":"B\u00fchring","year":"2004","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ymeth.2003.08.006","article-title":"Assays for measuring in\u00a0vitro basophil activation induced by recombinant allergens","volume":"32","author":"Valent","year":"2004","journal-title":"Methods"},{"key":"10.1016\/j.jaip.2019.01.006_bib55","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/039463200802100404","article-title":"CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking","volume":"21","author":"Hauswirth","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jaip.2019.01.006_bib56","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib57","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2013.06.020","article-title":"Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM","volume":"133","author":"Alvarez-Twose","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib58","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11882-014-0450-8","article-title":"Anaphylaxis as a clinical manifestation of clonal mast cell disorders","volume":"14","author":"Matito","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2019.01.006_bib59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","article-title":"Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology","volume":"137","author":"Hartmann","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000329856","article-title":"Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms","volume":"157","author":"Alvarez-Twose","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000336374","article-title":"Evaluation of mast cell activation syndromes: impact of pathology and immunohistology","volume":"159","author":"Horny","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib62","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaci.2018.06.004","article-title":"Mast cell activation syndrome: importance of consensus criteria and call for research","volume":"142","author":"Valent","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib63","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaip.2019.01.006_bib64","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jaci.2013.11.039","article-title":"Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities","volume":"133","author":"Lyons","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib65","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2019.01.006_bib66","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/gim.2017.136","article-title":"A\u00a0common haplotype containing functional CACNA1H variants is frequently coinherited with increased TPSAB1 copy number","volume":"20","author":"Lyons","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.jaip.2019.01.006_bib67","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10875-018-0506-y","article-title":"First identification of an inherited TPSAB1 quintuplication in a patient with clonal mast cell disease","volume":"38","author":"Sabato","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib68","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood.V98.7.2200","article-title":"Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia","volume":"98","author":"Sperr","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2019.01.006_bib69","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1080\/10428190290021470","article-title":"Serum tryptase measurements in patients with myelodysplastic syndromes","volume":"43","author":"Sperr","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaip.2019.01.006_bib70","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2362.2009.02184.x","article-title":"Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology","volume":"39","author":"Sperr","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaip.2019.01.006_bib71","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/17474086.2014.955008","article-title":"The serum tryptase test: an emerging robust biomarker in clinical hematology","volume":"7","author":"Valent","year":"2014","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jaip.2019.01.006_bib72","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0091-6749(97)81058-5","article-title":"Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis","volume":"99","author":"Oude Elberink","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib73","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jaip.2017.11.025","article-title":"Anaphylactic reactions after discontinuation of hymenoptera venom immunotherapy: a clonal mast cell disorder should be suspected","volume":"6","author":"Bonadonna","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.01.006_bib74","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/cea.12369","article-title":"The presence of mast cell clonality in patients with unexplained anaphylaxis","volume":"44","author":"G\u00fclen","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.01.006_bib75","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaci.2014.06.031","article-title":"Recognizing mastocytosis in patients with anaphylaxis: value of KIT D816V mutation analysis of peripheral blood","volume":"135","author":"Broesby-Olsen","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib76","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/leu.2015.24","article-title":"KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis","volume":"29","author":"Arock","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2019.01.006_bib77","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/all.13187","article-title":"Prospective evaluation of the diagnostic value of sensitive KIT D816V mutation analysis of blood in adults with suspected systemic mastocytosis","volume":"72","author":"Kristensen","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.01.006_bib78","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","article-title":"A\u00a0distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis","volume":"141","author":"Carter","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.006_bib79","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/modpathol.2015.72","article-title":"Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications","volume":"28","author":"Jara-Acevedo","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaip.2019.01.006_bib80","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations","volume":"130","author":"Bodemer","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2019.01.006_bib81","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/bjd.16795","article-title":"Pediatric mastocytosis: long-term follow-up of 53 patients with whole sequencing of KIT. A prospective study","volume":"179","author":"M\u00e9ni","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.01.006_bib82","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11882-015-0525-1","article-title":"Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?","volume":"15","author":"Matito","year":"2015","journal-title":"Curr Allergy Asthma Rep"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981930056X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981930056X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:20:13Z","timestamp":1761974413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321981930056X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S221321981930056X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2019.01.006","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2019.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}